TECOGEN INC. awarded General Counsel and Secretary Whiting John Kimball IV 19,342 shares at $0 per share on June 26, 2026. The award left him with 41,954 shares, giving investors a specific view of the insider’s post-transaction ownership and the size of the grant relative to that stake.
Key Highlights
- Whiting John Kimball IV owned 41,954 TECOGEN INC. Shares after the transaction.
- The shares were awarded on June 26, 2026, at $0 per share.
- TECOGEN INC. Awarded Whiting John Kimball IV 19,342 shares on June 26, 2026, at $0 per share.
TECOGEN INC. (AMEX: TGEN) awarded 19,342 shares to Whiting John Kimball IV at $0 per share. The recipient serves as the company’s General Counsel and Secretary, and his ownership after the transaction stood at 41,954 shares.
June 26 Award Recorded at Zero Cost
The transaction took place on June 26, 2026. The filing reports SEC transaction code A for the award. The shares were awarded at $0 per share. Whiting John Kimball IV held the General Counsel and Secretary positions at TECOGEN INC. When the award was recorded.
FAQs
Q: How many shares did TECOGEN INC. Award Whiting John Kimball IV?
A: TECOGEN INC. Awarded Whiting John Kimball IV 19,342 shares on June 26, 2026, at $0 per share. The filing records the award under SEC transaction code A.
Q: What was Whiting John Kimball IV’s ownership after the TECOGEN share award?
A: Whiting John Kimball IV owned 41,954 TECOGEN INC. Shares after the transaction. He serves as General Counsel and Secretary of the company.
Q: When did the TECOGEN share award occur, and what SEC transaction code was reported?
A: The transaction took place on June 26, 2026. The filing identifies the award with SEC transaction code A and records the shares at zero dollars per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.